Lilotomab Antibody

SKU: orb1980381

Description

Lilotomab (HH1) is a murine monoclonal antibody targeting CD37. Its radiolabeled conjugate, ¹⁷⁷Lu-lilotomab satetraxetan, is a synthetic radioimmunotherapeutic agent used in preclinical research for targeting B-cell malignancies in both in vitro and in vivo experimental models.

Research Area

Cell Biology

Images & Validation

−

Key Properties

−

CAS Number	1453362-55-4
MW	145.23 kDa
Purity	95.00%
Target	Apoptosis

Bioactivity

−

In Vivo	In a mouse model, Lilotomab (0.5 mg/kg, i.v., single dose) effectively inhibited tumor growth.
In Vitro	Lilotomab (0-40 µg/mL, treated for 12 days) significantly reduced clone formation survival of DOHH2 and Ramos cells. Lilotomab (40 µg/mL, 18 hours of treatment) produced mild apoptotic effects on DOHH2 cells. Read more...

Storage & Handling

−

Storage	Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

apoptosis, HH1

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Quick Database Links

Gene Symbol

Apoptosis

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols